Bain, KKR, KV Asia shortlisted for Malaysia's Avisena stake sale; firm valuation is RM1.5bil, sources say
自動翻訳Bain, KKR, KV Asia short上場 向け Malaysia's Avisena stake sale; 企業 valuatiについて is RM1.5bil, sources say
SINGAPORE: Bain Capital, KKR and KV Asia Capital have been shortlisted to buy a minority stake in Avisena Healthcare in a deal that could value the Malaysian healthcare firm at about RM1.5bil, two people with direct knowledge of the matter said.
自動翻訳SINGAPORE: Bain Capital, KKR and KV Asia Capital have been short上場 to buy a minority stake in Avisena Healthcare in a deal that could value the Malaysian healthcare 企業 at about RM1.5bil, two people と direct knowledge of the matter 発言.
本記事は、マレーシア B2B 市場の足元動向を伝えるもので、進出・提携・出資検討の判断材料となる。Bursa 上場銘柄・大手非上場・MNC 現地法人の動きは、Merca データベースで対応エンティティを確認することで戦略への翻訳が可能。
※ Merca のカテゴリ別解析テンプレートに基づく自動コメンタリーで、記事執筆者の見解ではありません。具体的な戦略判断は一次ソース・専門家への確認を推奨します。
AstraZeneca’s Q2 net profit rises on strong cancer drug sales
Free Malaysia Today | FMT
US to resume Mexican cattle imports after yearlong halt
Free Malaysia Today | FMT
Malaysia’s durian growers face oversupply squeeze even as exports to China hit record highs
Malay Mail
World Bank confirms plan to phase out China lending by 2031 as partnership shifts to knowledge sharing
Malay Mail